Crystal structure of a soluble CD28-Fab complex

被引:145
作者
Evans, EJ
Esnouf, RM
Manso-Sancho, R
Gilbert, RJC
James, JR
Yu, C
Fennelly, JA
Vowles, C
Hanke, T
Walse, B
Hünig, T
Sorensen, P
Stuart, DI
Davis, SJ
机构
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England
[3] TeGenero AG, D-97076 Wurzburg, Germany
[4] Act Biotech Res AB, SE-22007 Lund, Sweden
[5] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1038/ni1170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naive T cell activation requires signaling by the T cell receptor and by nonclonotypic cell surface receptors. The most important costimulatory protein is the monovalent homodimer CD28, which interacts with CD80 and CD86 expressed on antigen-presenting cells. Here we present the crystal structure of a soluble form of CD28 in complex with the Fab fragment of a mitogenic antibody. Structural comparisons redefine the evolutionary relationships of CD28-related proteins, antigen receptors and adhesion molecules and account for the distinct ligand-binding and stoichiometric properties of CD28 and the related, inhibitory homodimer CTLA-4. Cryo-electron microscopy-based comparisons of complexes of CD28 with mitogenic and nonmitogenic antibodies place new constraints on models of antibody-induced receptor triggering. This work completes the initial structural characterization of the CD28-CTLA-4-CD80-CD86 signaling system.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 53 条
  • [1] CD28-mediated co-stimulation: A quantitative support for TCR signalling
    Acuto, O
    Michel, F
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (12) : 939 - 951
  • [2] A dissection of specific and non-specific protein - Protein interfaces
    Bahadur, RP
    Chakrabarti, P
    Rodier, F
    Janin, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2004, 336 (04) : 943 - 955
  • [3] CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)
    BOISE, LH
    MINN, AJ
    NOEL, PJ
    JUNE, CH
    ACCAVITTI, MA
    LINDSTEN, T
    THOMPSON, CB
    [J]. IMMUNITY, 1995, 3 (01) : 87 - 98
  • [4] Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789
  • [5] LICOS, a primordial costimulatory ligand?
    Brodie, D
    Collins, AV
    Iaboni, A
    Fennelly, JA
    Sparks, LM
    Xu, XN
    van der Merwe, PA
    Davis, SJ
    [J]. CURRENT BIOLOGY, 2000, 10 (06) : 333 - 336
  • [6] The immunological synapse and CD28-CD80 interactions
    Bromley, SK
    Iaboni, A
    Davis, SJ
    Whitty, A
    Green, JM
    Shaw, AS
    Weiss, A
    Dustin, ML
    [J]. NATURE IMMUNOLOGY, 2001, 2 (12) : 1159 - 1166
  • [7] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [8] BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
  • [9] Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells:: Application to glycoprotein crystallization
    Butters, TD
    Sparks, LM
    Harlos, K
    Ikemizu, S
    Stuart, DI
    Jones, EY
    Davis, SJ
    [J]. PROTEIN SCIENCE, 1999, 8 (08) : 1696 - 1701
  • [10] The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses
    Carreno, BM
    Collins, M
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 : 29 - 53